169 related articles for article (PubMed ID: 3104814)
1. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
2. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
Miyamoto M; Nagawa Y
Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
Crespi F; Keane PE; Morre M
Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
[TBL] [Abstract][Full Text] [Related]
5. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
6. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
[TBL] [Abstract][Full Text] [Related]
7. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
8. Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area.
Sánchez MS; Barontini M; Armando I; Celis ME
Cell Mol Neurobiol; 2001 Oct; 21(5):523-33. PubMed ID: 11860189
[TBL] [Abstract][Full Text] [Related]
9. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
11. TRH injected into the nucleus accumbens shell releases dopamine and reduces feeding motivation in rats.
Puga L; Alcántara-Alonso V; Coffeen U; Jaimes O; de Gortari P
Behav Brain Res; 2016 Jun; 306():128-36. PubMed ID: 27006143
[TBL] [Abstract][Full Text] [Related]
12. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
Kalivas PW; Bronson M
Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
[TBL] [Abstract][Full Text] [Related]
13. A study of the changes in motor behaviour caused by TRH on intracerebral injection.
Costall B; Hui SC; Metcalf G; Naylor RJ
Eur J Pharmacol; 1979 Jan; 53(2):143-50. PubMed ID: 103733
[TBL] [Abstract][Full Text] [Related]
14. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
15. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
16. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
You ZB; Chen YQ; Wise RA
Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of TRH in the release of [3H]-dopamine from rat nucleus accumbens-lateral septum slices.
Méndez M; Morán J; Wilk S; Joseph-Bravo P; Charli JL
Brain Res Bull; 1993; 31(5):621-5. PubMed ID: 8098657
[TBL] [Abstract][Full Text] [Related]
18. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
de Souza Silva MA; Topic B; Huston JP; Mattern C
Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
[TBL] [Abstract][Full Text] [Related]
19. Substance P modulation of the mesolimbic dopamine system.
Kalivas P
Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
